1. Market Research
  2. > Business Services Market Trends
  3. > Research and Development

How to kick-start your R&D industry analysis using the latest figures

  • Currently 4/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
1 vote

Global Research & Development Industry


The global research and development (R&D) industry is included in business services and encompasses three main fields of activity, which are basic research, applied research and development. Two central branches of the industry involve R&D in engineering, physical and life sciences on one hand, and the humanities and social sciences on the other.


R&D involves carrying out creative work to expand the knowledge base, and then use that base to improve existing products and processes and to create new products and processes. Company survival relies on innovation, which is encouraged by R&D. Industrial companies in the US invest an average of almost 4% of revenue in R&D, while in the high technology sector this rises closer to 7%. In the pharmaceutical sector the percentage of revenue dedicated to R&D can be higher, such as Novartis at 15%, Merck & Co at 14% and Ericsson at almost 25%.


Key Market Segments


Technology - Sensors manufacturing is becoming easier in terms of quantity and adaptability as technological advances make it easier to produce more sensors and sensors that can be incorporated into smaller devices. Sensors are vital to the functioning of most electronics-based devices, instruments and equipment used in domains that necessitate measuring. Fuji Keizai USA notes the huge potential for sensor research and development (R&D), encompassing various types of sensors, including extreme temperature sensors, multi-axis sensors, accelerometers, wireless sensors, in vivo sensors, millimeter-wave radar sensors and pressure sensors.


Health - Datamonitor estimates there are more than 135 products being developed in the sector of women’s health, which is a sector that has witnessed a falling off in investment over recent years as other therapy areas promising greater return on investment were favored by the pharmaceutical industry. New therapeutics in women’s health cover a wide range of preclinical and clinical level conditions. The leading segments concern menopausal symptoms and contraceptives. Though endometriosis and uterine fibroids represent appealing markets in the women’s health sector, both innovation and investment remain low. Oral gonadotropin releasing hormone antagonists are likely short-term candidates, and diagnostic and biomarker research is likely to be strong long term. Investment in drug discovery is weak due to a perception of lower return on investment. Patient access is likely to fuel long-term market expansion rather than drug advances. Treatment demand will be fuelled by a widening treatable population, with contraceptives and infertility treatments representing the leading segment.


Pharmaceuticals - The global pharmaceutical industry avails of R&D to assess health technology for new products and to gather the economic analyses necessary for effective decision making. Business Insights points to the importance for pharmaceutical companies of taking HTA requirements for new drugs into account. Prior to the launch of a new product on the market, it is vital for companies to explore factors such as treatment heterogeneity, costs associated with a condition, patient perspectives, unmet needs and existing practices. Throughout phase III trials, data can be gathered to support positive reimbursement decisions. Treatment costs are coming to light more and more often following US healthcare reform. The FDA and Centers for Medicare and Medicaid Services are examining the review process. Kalorama Information estimates the average drug takes up to 15 years at a cost of $1.3 billion to bring to market. There is, therefore, an increasing degree of outsourcing of various development phases, with contract research organizations recording growing demand.



Regional Markets


In 2010, the US Scientific Research and Development industry witnessed a near 5% drop in corporate funding following the economic crisis, reports IBIS World. State investment in R&D similarly decreased due to the difficult economic climate. Nonetheless, overall industry revenue recorded yearly growth in excess of 2% to exceed $85 billion. State funding has traditionally been used for basic research, while corporate and private funding often goes to developmental and experimental research to take basic research further. The latter is perceived as more viable, with private investors more likely to invest in this type of research in hope of greater returns.



Market Outlook


The high degree of technology involved in the scientific R&D services industry means that it is in a constant state of flux. Cutting edge technologies such as biotechnology and nanotechnology are opening up the realm of R&D. Evolving knowledge also drives the R&D sector, with growing understanding of physics, chemistry and genetics fuelling technological advances.



Leading Industry Associations




You might be interested in these related markets


Understand the Research & Development Industry Quickly & Get Actionable Data Easily. The Latest Reports with Statistics & Trends from Top Industry Sources
1-10 of about 3 700 reports

Global Research And Development Supply

  • March 2015
    227 pages
  • World  


View report >

Research Center Industry in the US and Mexico

  • November 2015
    33 pages
  • Research Center  

  • United States  


    North America  

View report >

Research And Development Industry in Europe

  • October 2015
    27 pages
  • Research and De  

  • Europe  


View report >

Research And Development Industry in Asia

  • May 2015
    18 pages
  • Research and De  

  • Asia  

    United States  

View report >

Research And Development Industry in Japan Forecast

  • January 2014
    33 pages
  • Research and De  

    Molecular Techn  

  • Japan  

View report >

Research And Development Industry in Germany

  • July 2015
    25 pages
  • Research and De  

  • Germany  

View report >

Research And Development Industry in the UK

  • October 2015
    6 pages
  • Research and De  

  • United Kingdom  

View report >

Research And Development Industry in Canada

  • October 2015
    19 pages
  • Research and De  

  • Canada  

    United States  

View report >

About 1 600 reports

Purchase Reports From Reputable Market Research Publishers
(From € 115 - € 5 560)

Asia-Pacific Regulations Driving Innovation in Healthcare 

Asia-Pacific Regulations Driving Innovation in Healthcare 

  • € 5 560
  • Industry report
  • October 2015
  • by Frost & Sullivan

About this Study Innovation is fundamental to the growth of the healthcare market In recent years, many governments in the Asia-Pacific (APAC) region have rolled out favorable regulations to encourage ...

Executive Analysis Of The Global Operations Of Ford Mot ...

September 2015 € 5 560

Global Big Data Analytics Market For Test And Measureme ...

September 2015 € 5 560

Global Big Data Analytics Market For Test And Measureme ...

September 2015 € 5 560

Orthopedic Devices Global Market – Forecast To 2021

September 2015 € 3 600

Global Superconductors Market Outlook (2014-2022)

September 2015 € 3 320

Scientific Research & Development Service Lines World R ...

October 2015 € 2 438

Research & Development In The Social Sciences & Humanit ...

October 2015 € 2 438

R&d In Physical & Engineering Sciences Lines World Repo ...

October 2015 € 2 438

Research & Development In Social Sciences & Humanities ...

October 2015 € 2 438

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.